Namiko Tomatsu

Namiko Tomatsu

Auto-generated profile, based on publicly available information

Namiko Tomatsu

Scientific Affairs Team, Planning Group, Supplement Strategic Unit, Pharma & Supplemental Nutrition Solutions Vehicle Kaneka Corporation Tokyo Japan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2025 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
JSJinko Sawashita
Jinko Sawashita
SHShinichi Honda
Shinichi Honda
YTYUJI TOMINAGA
YUJI TOMINAGA
NTNamiko Tomatsu
Namiko Tomatsu
JEJordi Espadaler-Mazo
Jordi Espadaler-Mazo
TUTakahiro Ueda
Takahiro Ueda
Background and Purpose: Latilactobacillus sakei KABP‐065 derived from pickled vegetables of East Asia can improve skin condition in patients with atopic dermatitis through a mechanism that suppresses immune hyperactivity. Here we investigated whether KABP‐065 postbiotics can improve the facial skin condition of healthy middle‐aged women. Methods: Japanese women ( n = 60) aged ≥ 30 to < 50 years who met inclusion criteria were randomly assigned to postbiotic or placebo groups. The participants consumed capsules containing either heat‐treated KABP‐065 (1 × 10 10 cells/day) or placebo for 8 weeks. The effect of the postbiotic on skin condition parameters was assessed on the skin of the cheeks before the intervention, and at 5 and 8 weeks after the intervention. Subjective evaluations of skin conditions and mental and gastrointestinal symptoms, as well as safety evaluations, were also conducted. Results: Cheek skin moisture and transepidermal water loss improved for both groups after the intervention. The postbiotic group had significantly improved skin elasticity relative to the placebo group. A stratified analysis of participants in their 40s showed that, compared to the placebo group, the postbiotic group had a greater improvement in skin elasticity and a significantly greater improvement in cheek moisture. No exacerbation of gastrointestinal symptoms was seen with postbiotic supplementation, and the frequency of adverse events was similar between the postbiotic and placebo groups. Conclusion: KABP‐065 postbiotics could be effective for improving the skin condition of healthy women aged ≥ 30 to < 50 years, especially those in their 40s.